Atrial Fibrillation (AFib) is the most common heart rhythm disorder, affecting more than 40 million people worldwide.
The condition poses a five-fold increased risk of stroke, yet is often difficult to detect.
Until now, studies have shown the potential of smart devices for large-scale AFib screening but have made no comparison with conventional screening.
However new research presented at the...
The advantages of telehealth beyond enabling physician/patient relationships to continue virtually are now driving adoption in many aspects of care provision that were critically disrupted by the pandemic – most notably preventive healthcare, remote patient monitoring and chronic disease management.
While clinicians derive great value from the flexibility and efficiencies enabled by these digital...
06:13 am
December 16, 2021
The profound impact of COVID-19 has changed the lives of people all over the world.
As social distancing became the new normal, new patterns of behaviour and expectations emerged between patients and physicians.
One outcome of this has been an increase in the use of remote patient monitoring (RPM) technology, which can allow patients to receive treatment without travelling to hospital.
For...
The FDA has cleared the eMotion ECG Mobile, a Finnish continuous ECG monitor that connects to Android smartphones, as a Class 2 medical device. The ECG Mobile, made by Mega Electronics, already has a CE Mark and has been available for purchase in Europe since late 2012, but the company's securing of FDA clearance suggests it may be bringing the device to the United States to compete with mobile...
LifeWatch's CardGuard PMP4 Suite of Devices
A recently published study in the Journal of Medical Internet Research found that mobile phone-based heart failure telemonitoring was an easy to use solution that offered immediate feedback to both patients and clinicians. The small study -- just 22 heart failure patients used the mobile phone-based monitoring system for six months -- required patients...
